Dupilumab was reported to be effective in improving PnIF and FEV1, and was superior to mepolizumab which did not reach statistical significance in improving FEV1.
← all excerpts
Biologics for the treatment of chronic rhinosinusitis with nasal polyps - state of the art.
1
—
—